AstraZeneca

At the European Respiratory Society (ERS) Congress 2026, AstraZeneca presented the design of the Phase IIb PRESTO trial, a large…

AstraZeneca Pharma India has launched K+ Connect, a pan-India multidisciplinary initiative focused on advancing the management of…

AstraZeneca announced new Phase III clinical data for baxdrostat, an investigational, first-in-class, oral aldosterone synthase…

AstraZeneca India, a science-led biopharmaceutical company, is advancing its commitment to chronic respiratory care by extending…

Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that Cell therapy is entering a bold new phase…

AstraZeneca India, a leading global biopharmaceutical company has launched Eculizumab concentrate solution for infusion (300 mg,10…

Symbiosis played a pivotal role in the clinical development of the Oxford University/AstraZeneca COVID-19 vaccine

Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024

GlobalData’s latest report reveals that Iran’s clinical trials have been affected, with 348 trials initiated in Q2, compared to…

GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…